The impact of cognitive remediation on cognitive and self-reported psychosocial outcomes in individuals with schizophrenia or schizoaffective disorder

Not Applicable

Completed

• Conditions: Schizophrenia; Schizoaffective disorder; Mental Health - Schizophrenia

• Registration Number: ACTRN12616001476426
• Lead Sponsor: Monash University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-10-24
• Study Completion: 2017-03-31
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 56

Inclusion Criteria

Diagnosis of schizophrenia or schizoaffective disorder
- Aged between 18-65
- Participants clinically stable with no acute psychosis requiring hospitalisation within the last 8 weeks
- Fluency in English with an ability to comprehend research material

Exclusion Criteria

- Estimated intelligence quotient (IQ) of less than 80 (i.e. Borderline IQ or lower)
- History of any significant neurological injury or neurodegenerative disease known to impact cognition.
- Currently pregnant
- Substance dependence in the past 6 months
- Electroconvulsive therapy in the past 6 months
- Participation in any cognitively-enhancing research trial or intervention
- Significant sensory or motor impairments that may impact ability to use computers

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Independent living skills are measured using global and composite subscale scores on the Independent Living Skills Survey - Self-report (ILSS-SR).[Administered at baseline (prior to randomisation); immediately post-intervention (within 1 week post-intervention); and three-months post-intervention. ];Self efficacy measured using global and composite subscale scores on the Revised Self Efficacy Scale (RSES).[Administered at baseline (prior to randomisation); immediately post-intervention (within 1 week post-intervention); and three-months post-intervention. ];Change in objective cognitive functioning is measured using the MATRICS Consensus Cognitive Battery (MCCB).[Administered at baseline (prior to randomisation); immediately post-intervention (within 1 week post-intervention); and three-months post-intervention. ]